Harmony Biosciences Receives FDA Approval for Expanded Use of Wakix (pitolisant) for the Treatment Of Cataplexy in Adult Patients with Narcolepsy

PLYMOUTH MEETING, PA and CHICAGO, IL, October 13, 2020— Harmony Biosciences Holdings, Inc. ( " Harmony " ) (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients living with rare...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news